Skip to content

Drug interactions

Diltiazem + Larotrectinib

Severity: Moderate

Diltiazem and Larotrectinib: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Larotrectinib is a CYP3A4 substrate, so diltiazem may increase its concentrations and the risk of adverse effects such as hepatotoxicity, dizziness, and neurotoxicity. The label advises avoiding strong inhibitors, and moderate inhibitors are less well studied.

What this interaction means in plain words

Diltiazem and Larotrectinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Diltiazem belongs to Cardiovascular; Larotrectinib belongs to Oncology.

Evidence level: Low

Why it happens

Diltiazem inhibits CYP3A4 metabolism of larotrectinib.

What to do

Monitor liver enzymes and neurologic adverse effects, or choose an alternative to diltiazem.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Diltiazem and Larotrectinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Diltiazem with Larotrectinib?

MediHelp rates the interaction as moderate. Diltiazem and Larotrectinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Larotrectinib is a CYP3A4 substrate, so diltiazem may increase its concentrations and the risk of adverse effects such as hepatotoxicity, dizziness, and neurotoxicity. The label advises avoiding strong inhibitors, and moderate inhibitors are less well studied.

How serious is the interaction between Diltiazem and Larotrectinib?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor liver enzymes and neurologic adverse effects, or choose an alternative to diltiazem.

What other medicines interact with Diltiazem?

MediHelp also lists interactions of Diltiazem with, for example, Flibanserin, Ivabradine, Lomitapide. The full list is on the Diltiazem page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in